Antigen presentation by Langerhans cells

Current Opinion in Immunology

Volumn 25, Issue 1, 2013, Pages 115-119

  Igyártó, Botond Z ^a   Kaplan, Daniel H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; LANGERIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; CANDIDA ALBICANS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLEC9A GENE; CROSS PRESENTATION; CROSS TOLERANCE; DERMATOMYCOSIS; GENE; GENE EXPRESSION; HERPES SIMPLEX; HUMAN; LANGERHANS CELL; MEASLES VIRUS; NONHUMAN; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL; XCR1 GENE;

ADAPTIVE IMMUNITY; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLULAR MICROENVIRONMENT; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-17; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MICE; SKIN;

EID: 84875240088     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.11.007     Document Type: Review

References (37)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. Merad M., Ginhoux F., Collin M. Origin, homeostasis and function of Langerhans cells and other Langerin-expressing dendritic cells. Nat Rev Immunol 2008, 8:935-947.
3. Romani N., Clausen B.E., Stoitzner P. Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin. Immunol Rev 2010, 234:120-141.
4. Romani N., Brunner P.M., Stingl G. Changing views of the role of Langerhans cells. J Invest Dermatol 2012, 132:872-881.
5. Kaplan D.H. In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol 2010, 31:446-451.
6. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
7. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol 2012, 12:557-569.
8. Klechevsky E., Morita R., Liu M., Cao Y., Coquery S., Thompson-Snipes L., Briere F., Chaussabel D., Zurawski G., Palucka A.K., et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008, 29:497-510.
9. Stoitzner P., Tripp C.H., Eberhart A., Price K.M., Jung J.Y., Bursch L., Ronchese F., Romani N. Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci USA 2006, 103:7783-7788.
10. Holcmann M., Stoitzner P., Drobits B., Luehrs P., Stingl G., Romani N., Maurer D., Sibilia M. Skin inflammation is not sufficient to break tolerance induced against a novel antigen. J Immunol 2009, 183:1133-1143.
11. Bursch L.S., Rich B.E., Hogquist K.A. Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J Immunol 2009, 182:4657-4664.
12. Nichols L.A., Chen Y., Colella T.A., Bennett C.L., Clausen B.E., Engelhard V.H. Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. J Immunol 2007, 179:993-1003.
13. Idoyaga J., Cheong C., Suda K., Suda N., Kim J.Y., Lee H., Park C.G., Steinman R.M. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J Immunol 2008, 180:3647-3650.
14. Stoitzner P., Green L.K., Jung J.Y., Price K.M., Tripp C.H., Malissen B., Kissenpfennig A., Hermans I.F., Ronchese F. Tumor immunotherapy by epicutaneous immunization requires Langerhans cells. J Immunol 2008, 180:1991-1998.
15. Bobr A., Olvera-Gomez I., Igyarto B.Z., Haley K.M., Hogquist K.A., Kaplan D.H. Acute ablation of Langerhans cells enhances skin immune responses. J Immunol 2010, 185:4724-4728.
16. Olvera-Gomez I., Hamilton S.E., Xiao Z., Guimaraes C.P., Ploegh H.L., Hogquist K.A., Wang L., Jameson S.C. Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination. Proc Natl Acad Sci USA 2012, 109:2072-2077.
17. Wang L., Bursch L.S., Kissenpfennig A., Malissen B., Jameson S.C., Hogquist K.A. Langerin expressing cells promote skin immune responses under defined conditions. J Immunol 2008, 180:4722-4727.
18. Allan R.S., Smith C.M., Belz G.T., van Lint A.L., Wakim L.M., Heath W.R., Carbone F.R. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003, 301:1925-1928.
19. Bosnjak L., Miranda-Saksena M., Koelle D.M., Boadle R.A., Jones C.A., Cunningham A.L. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol 2005, 174:2220-2227.
20. He Y., Zhang J., Donahue C., Falo L.D. Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 2006, 24:643-656.
21. Bedoui S., Whitney P.G., Waithman J., Eidsmo L., Wakim L., Caminschi I., Allan R.S., Wojtasiak M., Shortman K., Carbone F.R., et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 2009, 10:488-495.
22. Henri S., Poulin L.F., Tamoutounour S., Ardouin L., Guilliams M., de Bovis B., Devilard E., Viret C., Azukizawa H., Kissenpfennig A., et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 2010, 207:189-206.
23. Crozat K., Tamoutounour S., Vu Manh T.P., Fossum E., Luche H., Ardouin L., Guilliams M., Azukizawa H., Bogen B., Malissen B., et al. Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8alpha+ type. J Immunol 2011, 187:4411-4415.
24. Igyarto B.Z., Haley K., Ortner D., Bobr A., Gerami-Nejad M., Edelson B.T., Zurawski S.M., Malissen B., Zurawski G., Berman J., et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011, 35:260-272.
25. Flacher V., Tripp C.H., Stoitzner P., Haid B., Ebner S., Del Frari B., Koch F., Park C.G., Steinman R.M., Idoyaga J., et al. Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J Invest Dermatol 2010, 130:755-762.
26. van der Vlist M., de Witte L., de Vries R.D., Litjens M., de Jong M.A., Fluitsma D., de Swart R.L., Geijtenbeek T.B. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4(+) T cells but are incapable of cross-presentation. Eur J Immunol 2011, 41:2619-2631.
27. Haniffa M., Shin A., Bigley V., McGovern N., Teo P., See P., Wasan P.S., Wang X.N., Malinarich F., Malleret B., et al. Human tissues contain CD141(hi) cross-presenting dendritic cells with functional homology to mouse CD103(+) nonlymphoid dendritic cells. Immunity 2012, 37:60-73.
28. Jiang X., Clark R.A., Liu L., Wagers A.J., Fuhlbrigge R.C., Kupper T.S. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 2012, 483:227-231.
29. Romani N., Koide S., Crowley M., Witmer-Pack M., Livingstone A.M., Fathman C.G., Inaba K., Steinman R.M. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989, 169:1169-1178.
30. Romani N., Lenz A., Glassel H., Stossel H., Stanzl U., Majdic O., Fritsch P., Schuler G. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 1989, 93:600-609.
31. Schuler G., Steinman R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985, 161:526-546.
32. Stingl G., Gazze-Stingl L.A., Aberer W., Wolff K. Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light. J Immunol 1981, 127:1707-1713.
33. Stingl G., Katz S.I., Clement L., Green I., Shevach E.M. Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol 1978, 121:2005-2013.
34. Haley K., Igyarto B.Z., Ortner D., Bobr A., Kashem S., Schenten D., Kaplan D.H. Langerhans cells require MyD88-dependent signals for Candida albicans response but not for contact hypersensitivity or migration. J Immunol 2012, 188:4334-4339.
35. Nakajima S., Igyarto B.Z., Honda T., Egawa G., Otsuka A., Hara-Chikuma M., Watanabe N., Ziegler S.F., Tomura M., Inaba K., et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol 2012, 129:1048-1055. e1046.
36. Shklovskaya E., O'Sullivan B.J., Ng L.G., Roediger B., Thomas R., Weninger W., Fazekas de St Groth B. Langerhans cells are precommitted to immune tolerance induction. Proc Natl Acad Sci USA 2011, 108:18049-18054.
37. Seneschal J., Clark R.A., Gehad A., Baecher-Allan C.M., Kupper T.S. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 2012, 36:873-884.